Chemotherapy and Liver Transplantation for Patients With Unresectable Colorectal Liver Metastases
Rene Adam, MD, PhD, Paul Brousse Hospital, Villejuif, France, discusses results from the TRANSMET trial which demonstrated that liver transplantation combined with chemotherapy significantly improved survival among patients with unresectable liver metastases.
According to Dr Adam, “These [results] open a new way in treating a patient with unresectable liver metastases promised to a very poor outcome, by a new strategy which clearly increases survival and the option of cure.”
Source:
Adam R. Chemotherapy and liver transplantation versus chemotherapy alone in patients with definitively unresectable colorectal liver metastases: A prospective multicentric randomized trial (TRANSMET). Presented at the ASCO Annual Meeting. May 31-June 4, 2024; Chicago, IL. Abstract #3500